The role of peripheral T-cell deletion in transplantation tolerance

Author(s): Wells AD, Li XC, Strom TB, Turka LA

Abstract

The apoptotic deletion of thymocytes that express self-reactive antigen receptors is the basis of central (thymic) self-tolerance. However, it is clear that some autoreactive T cells escape deletion in the thymus and exist as mature lymphocytes in the periphery. Therefore, peripheral mechanisms of tolerance are also crucial, and failure of these peripheral mechanisms leads to autoimmunity. Clonal deletion, clonal anergy and immunoregulation and/or suppression have been suggested as mechanisms by which 'inappropriate' T-lymphocyte responses may be controlled in the periphery. Peripheral clonal deletion, which involves the apoptotic elimination of lymphocytes, is critical for T-cell homeostasis during normal immune responses, and is recognized as an important process by which self-tolerance is maintained. Transplantation of foreign tissue into an adult host represents a special case of 'inappropriate' T-cell reactivity that is subject to the same central and peripheral tolerance mechanisms that control reactivity against self. In this case, the unusually high frequency of naive T cells able to recognize and respond against non-self-allogeneic major histocompatibility complex (MHC) antigens leads to an exceptionally large pool of pathogenic effector lymphocytes that must be controlled if graft rejection is to be avoided. A great deal of effort has been directed toward understanding the role of clonal anergy and/or active immunoregulation in the induction of peripheral transplantation tolerance but, until recently, relatively little progress had been made towards defining the potential contribution of clonal deletion. Here, we outline recent data that define a clear requirement for deletion in the induction of peripheral transplantation tolerance across MHC barriers, and discuss the potential implications of these results in the context of current treatment modalities used in the clinical transplantation setting.

Similar Articles

Costimulation blockade: towards clinical application

Author(s): Weaver TA, Charafeddine AH, Kirk AD

The B7 family revisited

Author(s): Greenwald RJ, Freeman GJ, Sharpe AH

T-cell clonal anergy

Author(s): Schwartz RH, Mueller DL, Jenkins MK, Quill H

Induction of immunologic tolerance for transplantation

Author(s): Rossini AA, Greiner DL, Mordes JP

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells

Author(s): Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, et al.

The BB/Wor rat and the balance hypothesis of autoimmunity

Author(s): Mordes JP, Bortell R, Doukas J, Rigby M, Whalen B, et al.

The pathogenesis of autoimmune diabetes mellitus

Author(s): Rossini AA, Mordes JP, Greiner DL

Induction of immunological tolerance to islet allografts

Author(s): Rossini AA, Parker DC, Phillips NE, Durie FH, Noelle RJ, et al.

CD28/B7 regulation of autoimmune diabetes

Author(s): Herold KG, Lenschow DJ, Bluestone JA

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

Author(s): Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, et al.

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

Author(s): Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, et al.

CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo

Author(s): Tang Q, Smith JA, Szot GL, Zhou P, Alegre ML, et al.

What's next in the pipeline

Author(s): Vincenti F, Kirk AD

Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154

Author(s): Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, et al.

Islet cell transplantation tolerance

Author(s): Rossini AA, Mordes JP, Greiner DL, Stoff JS

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

Author(s): Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

Author(s): Wells AD, Walsh MC, Bluestone JA, Turka LA

Differentiation of regulatory Foxp3+ T cells in the thymic cortex

Author(s): Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, et al.

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

Author(s): Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, et al.

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

Author(s): Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al.

Expansion of human regulatory T-cells from patients with type 1 diabetes

Author(s): Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, et al.

Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors

Author(s): Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, et al.

Insulin dependent diabetes mellitus hypothesis of autoimmunity

Author(s): Rossini AA, Handler ES, Greiner DL, Mordes JP